Skye Bioscience
SKYE
SKYE
73 hedge funds and large institutions have $71.3M invested in Skye Bioscience in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.72% less ownership
Funds ownership: 84.81% → 83.09% (-1.7%)
29% less capital invested
Capital invested by funds: $101M → $71.3M (-$29.3M)
Holders
73
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.31M | |
| 3 | +$95.1K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$90.7K |
| 5 |
BlackRock
New York
|
+$75.5K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.56M | |
| 3 | -$1.54M | |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$825K |
| 5 |
ACM
Altium Capital Management
New York
|
-$498K |